Evidence map›Paper›PMID 25392363›Full record

ArticleJournal of clinical microbiology2015

Does sequence type 33 of Shiga toxin-producing Escherichia coli O91 cause only mild symptoms?

Eriko Maeda, Koichi Murakami, Yoshiki Etoh, Daisuke Onozuka, Nobuyuki Sera, Nanami Asoshima, Mikiko Honda, Hiroshi Narimatsu, Sunao Iyoda, Masanori Watahiki and 1 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical microbiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Eriko MaedaFukuoka Institute of Health and Environmental Sciences, Dazaifu, Fukuoka, Japan.
Koichi MurakamiFukuoka Institute of Health and Environmental Sciences, Dazaifu, Fukuoka, Japan murakami@fihes.pref.fukuoka.jp.
Yoshiki EtohFukuoka Institute of Health and Environmental Sciences, Dazaifu, Fukuoka, Japan.
Daisuke OnozukaFukuoka Institute of Health and Environmental Sciences, Dazaifu, Fukuoka, Japan.
Nobuyuki SeraFukuoka Institute of Health and Environmental Sciences, Dazaifu, Fukuoka, Japan.
Nanami AsoshimaFukuoka City Institute of Hygiene and the Environment, Jigyohama, Fukuoka, Japan.
Mikiko HondaFukuoka City Institute of Hygiene and the Environment, Jigyohama, Fukuoka, Japan.
Hiroshi NarimatsuLaboratory of Microbiology, Oita Prefectural Institute of Health and the Environment, Oita, Japan.
Sunao IyodaDepartment of Bacteriology I, National Institute of Infectious Diseases, Toyama, Tokyo, Japan.
Masanori WatahikiToyama Institute of Health, Imizu, Toyama, Japan.
Shuji FujimotoDepartment of Health Sciences, Faculty of Medical Sciences, Kyushu University, Maidashi, Fukuoka, Japan.

Funding

Biotechnology and Biological Sciences Research Council
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Abdominal PainDiarrheaEscherichia coli InfectionsHumansMultilocus Sequence TypingPhylogenyShiga-Toxigenic Escherichia coli

Identifiers

PMID25392363
PMCPMC4290953

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.